๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin

โœ Scribed by G. Taliani; E. Guerra; R. Rosso; M. C. Badolato; G. Luzi; G. Sacco; R. Lecce; C. De Bac; F. Aiuti

Book ID
118677658
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
478 KB
Volume
35
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term beneficial effect of interfero
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
โœ Shi-Ming Lin; I-Shyan Sheen; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 2 views

To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5

Low risk of hepatitis B virus recurrence
Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy
โœ Stephen N. Wong; Chi-Jen Chu; Chun-Tao Wai; Terese Howell; Charles Moore; Robert ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

Hepatitis B virus (HBV) recurrence rates of 0-16% had been reported in patients maintained on nucleoside analogues (NA) after hepatitis B immunoglobulin (HBIG) discontinuation after orthotopic liver transplantation (OLT). However, follow-up in most studies was short. We aimed to determine the long-t